Cross-specialty identification of the JAK1 inhibitor trial agent filgotinib as a potential therapy for alopecia areata

Published Date: 25th November 2022

Publication Authors: Meah N

 

Fagan, N; Doherty, Meah, N; Sinclair, R; Wall, D. (2022). Cross-specialty identification of the JAK1 inhibitor trial agent filgotinib as a potential therapy for alopecia areata. British Journal of Dermatology. epub 25 Nov. [Online]. Available at: https://doi.org/10.1093/bjd/ljac103 [Accessed 21 February 2023]

 

« Back